Search Results - "Izrael, V"

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer by André, T, Louvet, C, Maindrault-Goebel, F, Couteau, C, Mabro, M, Lotz, J.P, Gilles-Amar, V, Krulik, M, Carola, E, Izrael, V, de Gramont, A

“…CPT-11 (irinotecan) has shown activity in patients with advanced colorectal cancer resistant to leucovorin (LV) and 5-fluorouracil (5-FU). In this study, the…”
Get full text

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6) by Maindrault-Goebel, F, Louvet, C, André, T, Carola, E, Lotz, J.P, Molitor, J.L, Garcia, M.L, Gilles-Amar, V, Izrael, V, Krulik, M, de Gramont, A

“…For patients resistant to leucovorin (LV) and 5-fluorouracil (5-FU), the addition of oxaliplatin (85 or 100 mg/m 2) to bimonthly LV–5-FU has given a response…”
Get full text

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer by Maindrault-Gæbel, F., de Gramont, A., Louvet, C., André, T., Carola, E., Gilles, V., Lotz, J.-P., Tournigand, C., Mabro, M., Molitor, J.-L., Artru, P., Izrael, V., Krulik, M.

“…Background studies of bimonthly 48-hour regimens of high-dose leucovorin (LV) (FOLinic acid), 5-fluorouracil (5-FU) by continuous infusion combined with…”
Get full text

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7) by Maindrault-Gœbel, F, de Gramont, A, Louvet, C, André, T, Carola, E, Mabro, M, Artru, P, Gilles, V, Lotz, J.P, Izrael, V, Krulik, M

“…This phase II study examined a regimen (FOLFOX7) of leucovorin (LV), high-dose intensity oxaliplatin, and 5-fluorouracil (5-FU), as second-line therapy for…”
Get full text

Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma by André, T., Lotz, J. P., Bouleuc, C., Azzouzi, K., Houry, S., Hannoun, L., See, J., Esteso, A., Avenin, D., Izrael, V.

“…Summary Background. Advanced pancreatic adenocarcinoma is a rapidly fatal disease for which an active chemotherapy regimen is sought. Here we report the…”
Get full text

TEP à la fluoroéthyltyrosine (18F) pour la détection des tumeurs cérébrales by Nataf, V., Kerrou, K., Balogova, S., Pene, F., Huchet, V., Gutman, F., Prignon, A., Muresan, I.-P., Giannesini, C., Izrael, V., Schlienger, M., Talbot, J.-N.

“…La tomographie par émission de positons (TEP) à la fluoroéthyltyrosine (FET), analogue de l’acide aminé, a été pratiquée depuis le début de la décennie, en…”
Get full text

Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support by Lotz, J P, Izrael, V

Get more information

Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study by Machover, D, Grison, X, Goldschmidt, E, Zittoun, J, Lotz, J P, Metzger, G, Richaud, J, Hannoun, L, Marquet, J, Guillot, T

“…Potentiation of the antitumor activity of fluorouracil (5-FU) by folinic acid has been demonstrated in patients with colorectal adenocarcinoma. Modulation is…”
Get more information

CA 15-3 and bone scintigraphy in the follow-up of breast cancer by Younsi, N, Montravers, F, Philippe, C, Seddiki, M, Uzan, S, Izrael, V, Talbot, J N

“…By means of the retrospective study of the clinical records of 158 women followed for breast cancer, we aimed to evaluate the consequences of a non-systematic…”
Get more information

The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease by Lotz, J P, André, T, Bouleuc, C, Péne, F, Gattegno, B, Bazelly, B, Houry, S, Chapiro, J, Selle, F, Gligorov, J, Izrael, V

Get more information

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer by Touboul, E, Buffat, L, Belkacémi, Y, Lefranc, J P, Uzan, S, Lhuillier, P, Faivre, C, Huart, J, Lotz, J P, Antoine, M, Pène, F, Blondon, J, Izrael, V, Laugier, A, Schlienger, M, Housset, M

“…To identify predicting factors for local failure and increased risk of distant metastases by statistical analysis of the data after breast-conserving treatment…”
Get more information

Initial chemoimmunotherapy in inflammatory carcinoma of the breast by Zylberberg, B, Salat-Baroux, J, Ravina, J H, Dormont, D, Amiel, J P, Diebold, P, Izrael, V

“…Fifteen patients with clinical primary inflammatory carcinoma of the breast were treated with initial chemoimmunotherapy between September 1974 and May 1977…”
Get more information

Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies by Jacquillat, C, Weil, M, Gemon-Auclerc, M F, Izrael, V, Bussel, A, Boiron, M, Bernard, J

“…Rubidazone was used as sole chemotherapy in 170 adults and children with acute leukemia and sarcoma. When rubidazone was employed to treat the first attack,…”
Get more information

Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting by Colbert, N, Izrael, V, Lotz, J P, Stoppa-Lyonnet, D, Vannetzel, J M, Pene, F, Schlienger, M, Laugier, A

“…A double-blind trial to evaluate the antiemetic effects of adrenocorticotropic hormone (ACTH) in patients treated with cisplatin was performed. Thirty-seven…”
Get more information

Survival of 410 patients (pts) with solid tumors following high-dose chemotherapy (HDCT): A single center experience on 650 autologous haematopoietic stem-cell transplantation by Saintigny, P., Lotz, J.-P., Selle, F., Gligorov, J., Provent, S., Saavedra, A., Nakry, T., Bertheloot, L., Izrael, V.

“…Abstract only…”
Get full text

Survival of 410 patients (pts) with solid tumors following high-dose chemotherapy (HDCT): A single center experience on 650 autologous haematopoietic stem-cell transplantation by Saintigny, P., Lotz, J.-P., Selle, F., Gligorov, J., Provent, S., Saavedra, A., Nakry, T., Bertheloot, L., Izrael, V.

“…Abstract only…”
Get full text

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study by André, T, Balosso, J, Louvet, C, Hannoun, L, Houry, S, Huguier, M, Colonna, M, Lotz, J P, De Gramont, A, Bellaïche, A, Parc, R, Touboul, E, Izrael, V

“…To evaluate a cisplatin-containing chemoradiotherapy (CRT) regimen followed by chemotherapy for unresectable (locally advanced group, n = 32) and resected…”
Get more information

Combination therapy in 130 patients with acute lymphoblastic leukemia (protocol 06 LA 66-Paris) by Jacquillat, C, Weil, M, Gemon, M F, Auclerc, G, Loisel, J P, Delobel, J, Flandrin, G, Schaison, G, Izrael, V, Bussel, A, Dresch, C, Weisgerber, C, Rain, D, Tanzer, J, Najean, Y, Seligmann, M, Boiron, M, Bernard, J

Get full text

Erratum to “High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as a second-line therapy for metastatic colorectal cancer (FOLFOX 7)” [European Journal of Cancer 37 (2001) 1000–1005] by Maindrault-Gœbel, F., de Gramont, A., Louvet, C., André, T., Carola, E., Mabro, M., Artru, P., Gilles, V., Lotz, J.P., Izrael, V., Krulik, M.

Get full text

Regression of sclerodermatous skin lesions in a patient with carcinoid syndrome treated by octreotide by Pavlovic, M, Saiag, P, Lotz, J P, Marinho, E, Clerici, T, Izrael, V

Get more information